mTOR: Alzheimer's disease prevention for APOE4 carriers

被引：6
|
作者：
Lin, Ai-Ling [1 ,2 ]
Butterfield, D. Allan
Richardson, Arlan
机构：
[1] Univ Kentucky, Sanders Brown Ctr Aging, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40506 USA
来源：
ONCOTARGET | 2016年 / 7卷 / 29期
关键词：
rapamycin; mTOR; Alzheimer's disease; cerebral blood flow; blood brain barrier; RAPAMYCIN; INTEGRITY;
D O I：
10.18632/oncotarget.10349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：44873 / 44874
页数：2
相关论文
共 50 条
  • [1] Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers
    Norwitz, Nicholas G.
    Saif, Nabeel
    Ariza, Ingrid Estrada
    Isaacson, Richard S.
    [J]. NUTRIENTS, 2021, 13 (04)
  • [2] Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
    Chetelat, G.
    Fouquet, M.
    [J]. REVUE NEUROLOGIQUE, 2013, 169 (10) : 729 - 736
  • [3] APOE4 testing for Alzheimer's disease
    Karlawish, JHT
    Sachs, GA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1153 - 1154
  • [4] A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers
    Bullido, Maria J.
    Martinez-Garcia, Ana
    Artiga, Maria J.
    Aldudo, Jesus
    Sastre, Isabel
    Gil, Pedro
    Coria, Francisco
    Munoz, David G.
    Hachinski, Vladimir
    Frank, Ana
    Valdivieso, Fernando
    [J]. NEUROBIOLOGY OF AGING, 2007, 28 (04) : 519 - 523
  • [5] Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
    Beeri, MS
    Rapp, M
    Silverman, JM
    Schmeidler, J
    Grossman, HT
    Fallon, JT
    Purohit, DP
    Perl, DP
    Siddiqui, A
    Lesser, G
    Rosendorff, C
    Haroutunian, V
    [J]. NEUROLOGY, 2006, 66 (09) : 1399 - 1404
  • [6] Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
    Vance, Jeffery M.
    Farrer, Lindsay A.
    Huang, Yadong
    Cruchaga, Carlos
    Hyman, Bradley T.
    Pericak-Vance, Margaret A.
    Goate, Alison M.
    Greicius, Michael D.
    Griswold, Anthony J.
    Haines, Jonathan L.
    Julia, T. C. W.
    Schellenberg, Gerard D.
    Tsai, Li-Huei
    Herz, Joachim
    Holtzman, David M.
    [J]. ANNALS OF NEUROLOGY, 2024, 95 (04) : 625 - 634
  • [7] ApoE4: A RISK FACTOR FOR ALZHEIMER'S DISEASE
    Agarwala, A.
    Durakoglugil, M.
    Xian, D.
    Bowen, I
    Herz, J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (02) : 469 - 469
  • [8] Epigenetic Downregulation of ApoE4 for Alzheimer's Disease
    Asmus, Natalie
    Moncalvo, Malik
    Dong, Wendy
    Ilich, Ekaterina
    Falek, Carmel
    Rittiner, Joseph
    Tringali, Domenic
    Yun, Young
    Gu, Jeffrey
    Wei, Angela
    Yang, Anna
    Angrist, Misha
    Chiba-Falek, Ornit
    Kantor, Boris
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 430 - 430
  • [9] Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration
    Conejero-Goldberg, Concepcion
    Hyde, Thomas M.
    Chen, Shufen
    Herman, Mary M.
    Kleinman, Joel E.
    Davies, Peter
    Goldberg, Terry E.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (04) : 969 - 978
  • [10] Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease
    Theendakara, Veena
    Peters-Libeu, Clare A.
    Bredesen, Dale E.
    Rao, Rammohan V.
    [J]. MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 5243 - 5254
12345